
Viatris- Theramex deal for women's care products raises antitrust concerns in U.K.
Viatris makes progress on Ozempic patent challenge
Viatris receives offer to divest all of it's over the counter business
Viatris sells API & women's healthcare business in India for $1.2 billion - Moneycontrol
Viatris in talks to sell European OTC assets to CVC unit - report
18.96BUSD

See which Billionaires own this investment
Type
Common Stock
Exchange
NASDAQ
Currency Code
USD
Currency Name
US Dollar
Country Name
USA
Country ISO
US
ISIN
US92556V1061
CUSIP
92556V106
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Fiscal Year End
December
IPO date
-
Updated At
-
PE Ratio
-
PEG Ratio
1.05
Book Value
12.59
Dividend Share
0.48
Dividend Yield
2.88%
Earnings Share
-0.37
Wall Street Target Price
18.67
EPS Estimate Current Year
2.51
EPS Estimate Next Year
2.66
EPS Estimate Current Quarter
0.5998
EPS Estimate Next Quarter
0.6374
Most Recent Quarter
-
Revenue TTM
14,737,300,480
Gross Profit TTM
5,940,199,936
EBITDA
4,292,499,968
Profit Margin
-2.79%
Return On Assets TTM
2.67%
Return On Equity TTM
-2.75%
Revenue Per Share TTM
12.715
Qtly Revenue Growth YOY
4.90%
Diluted Eps TTM
-0.37
Qtly Earnings Growth YOY
-70.60%
Trailing PE
0.00
Forward PE
6
Price Sales TTM
1.2977
Price Book MRQ
1.3415
Enterprise Value Revenue
2
Enterprise Value EBITDA
11
157.05
3.37%4.59
0.22%185.50
0.00%36.20
0.00%11.50
-4.41%38.53
-1.83%38.53
-1.67%18.64
-0.43%37.02
-0.42%30.11
-0.17%Profit.com is operated by Darqube Ltd, registered in England and Wales under company number 12197411.
Profit.com is an educational, subscription-based software platform providing financial market analytics and simulated trading using real-time market data and virtual funds. All trading activity on the platform is simulated. No real capital is used, no customer deposits are collected, and no real-money trades are executed or facilitated.
Profit.com is not a broker and does not provide brokerage, investment, or other financial services or investment advice. All content, tools and features are provided for educational and informational purposes only. Simulated trading results are hypothetical and are not indicative of actual or future results. The terms “trading” and “trader” refer exclusively to simulated activity on Profit.com and should not be interpreted as real-money trading or investing.